Studies have shown that ASTX treatment ameliorates DM complications via ROS scavenging [16], anti-inflammatory action [17,18], activation of antioxidant defense systems [19,20], and upregulation of nuclear factor erythroid 2-related factor 2 (Nrf2) [21]. This evidence concerns the gene NFE2L2 and diabetes mellitus.